Phase II part of EORTC study 26101: The sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma.

Wolfgang Wick, Martin J. van den Bent, Thierry Gorlia et al.|Journal of Clinical Oncology|2016

Cited by 19